This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Acetylcholine Market

Market Insights on Acetylcholine covering sales outlook, demand forecast & up-to-date key trends

Acetylcholine Market By Product form (Liquid Form, Solid Form), Product type (Acetylcholine Chloride, Acetylcholine Bromide, Acetylcholine Fluoride, Acetylcholine Hydroxide, Others) Applications (Neurotransmitter, Vasodilator Agent, Cholinergic Agonists, Others) & Region - Forecast 2022-2032

Acetylcholine Market Overview

The global acetylcholine demand is projected to be valued at US$ 2. 5 billion in 2022, forecast to grow at a CAGR of 4.3% to be valued at US$ 4 Billion from 2022 to 2032. Growth is attributed to the rising demand for renovation projects and development in residential and commercial construction.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 2.2 Billion

Expected Market Value (2022)

US$ 2.5 Billion

Anticipated Forecast Value (2032)

US$ 4 Billion

Projected Growth Rate (2022-2032)

4.3 % CAGR

Acetylcholine (Ach) is a chemical compound derived from choline and acetic acid. It is a prescription drug used in the preparation of a parasympathomimetic drug for intraocular usage. Acetylcholine plays a vital role in the central nervous system as a neurotransmitter. It is used by organisms in all domains of life. Acetylcholine has two key receptors- nicotinic receptors and muscarinic receptors.

Acetylcholine acts at various sites within the central nervous system where it plays an inhibitory role. Moreover, acetylcholine act as a key force in the functions of the brain, such as working memory, linguistic skills, and ability to reason and use logic, creativity. Also, acetylcholine is utilized to activate our muscle’s involuntary movement, mobility, and coordination, other applications.

Which are Some Prominent Drivers Spearheading Acetylcholine Market Growth?

Demographic changes, globalization, and growth in population have contributed to the healthcare services and increased the demand of the pharmaceutical industry. Further, increased awareness of health among citizens, especially in developing countries, is boosting the government health programs which ultimately drive the growth of the global acetylcholine market by end of the forecast period.  The premium-priced life-saving drugs can act as leverage for the market development of ingredients including acetylcholine.

OTC (over-the-counter) drugs are medicines that can be bought without a prescription from the doctor as the FDA (Food and Drug Administration) considers them safe for use without medical supervision. These drugs have a solution to numerous problems, such as cough & cold, pain, sleeping problems, itches, weight problems, smoking cessation, and gastrointestinal problems. Brain functions that have been negatively affected by OTC (over-the-counter) medicines aren’t permanent. The brain will recover once neurotransmitter release (like acetylcholine) is helping to back up to the normal level. As a result, demand for acetylcholine is estimated to continuously increase due to its superior properties of acetylcholine.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Acetylcholine Industry?

As per the research, few patients are facing negative effects of acetylcholine-like depression, and the stringent regulations for acetylcholine synthesis in various economies. This is estimated to act as a restraining factor for the global acetylcholine market.

Why is Asia-Pacific Emerging as an Opportunistic Acetylcholine Market?

The increasing population in the Asia Pacific region is estimated to gain high demand for acetylcholine in the region. Moreover, South East Asia Pacific region is anticipated to be a significant platform for the global acetylcholine market in the upcoming few years due to rising pharmaceutical production and healthcare services

Moreover, In China, COPD is one of the most prevalent chronic diseases in the population older than 40 years of age, with an occurrence of 8.2% in 2013 and amplified to 13.6% in 2019 using a spirometry-based survey. A relatively higher prevalence with 13.7% to 13.4% was noted in Korea using a spirometry-based survey.

Based on recent market research in the Asia-Pacific region, it was summarized that the prevalence of COPD is between 6.2 to 19.1%

Nikhil Kaitwade
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why does North America Hold a Significant Share in the Acetylcholine Market?

North America is expected to account for a prominent revenue share in the global muscarinic acetylcholine receptor market owing to the high patient pool suffering from COPD and other disorders. In the United States, an estimated 16 million adults have COPD. Nevertheless, that may be an underestimate.

The American Lung Association (ALA) contemplates there may be as many as 24 million American adults living with COPD. Additionally, over 7 million U.S. women have COPD, and millions more are supposed to have symptoms, yet haven’t been analyzed.

Market Competition

Some of the key participants present in the global demand for Acetylcholine market include Tokyo Chemical Industry Co., Ltd, SIEGFRIED LTD, Merck KGaA, NeuroHealing Pharmaceuticals Inc., Karuna Pharmaceuticals Inc., and Sisco Research Laboratories Pvt. Ltd., Heptares Therapeutics Ltd, Toucan, Sumitomo Dainippon Pharma Co Ltd, AstraZeneca Plc, Anavex Life Sciences Corp and among others

  • In Dec 2020, AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion.
  • Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope of Report

Report Attribute

Details

Growth Rate

CAGR of 4.3% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Product Form
  • Applications
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Tokyo Chemical Industry Co. Ltd,
  • SIEGFRIED LTD,
  • Merck KGaA,
  • NeuroHealing Pharmaceuticals Inc.,
  • Karuna Pharmaceuticals Inc.
  • Sisco Research Laboratories Pvt.Ltd.,
  • Heptares Therapeutics Ltd
  • Toucan
  • Sumitomo Dainippon Pharma Co Ltd,
  • AstraZeneca Plc,
  • Anavex Life Sciences Corp

Customization

Available Upon Request

Key Segments Profiled in the Acetylcholine Industry Survey

Product Form:

  • Liquid Form
  • Solid Form

Product Type:

  • Acetylcholine Chloride
  • Acetylcholine Bromide
  • Acetylcholine Fluoride
  • Acetylcholine Hydroxide
  • Others

Applications:

  • Acetylcholine as a Neurotransmitter
  • Acetylcholine as a Vasodilator Agent
  • Acetylcholine as a Cholinergic Agonists
  • Acetylcholine for Other Applications

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global demand of the Acetylcholine market to expand at a 4.3% value CAGR by 2032

North America is expected to be the most opportunistic Acetylcholine market, expanding at a ~4% CAGR

Tokyo Chemical Industry Co., Ltd, SIEGFRIED LTD, Merck KGaA, NeuroHealing Pharmaceuticals Inc., Karuna Pharmaceuticals Inc., and Sisco Research Laboratories Pvt. Ltd., Heptares Therapeutics Ltd, Toucan, Sumitomo Dainippon Pharma Co Ltd, AstraZeneca Plc, Anavex Life Sciences Corp and among others

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Nikhil Kaitwade
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Chemicals & Materials Insights

View Reports
Google translate